← Back to Search

Cognitive Intervention for Schizophrenia

N/A
Waitlist Available
Led By Synthia Guimond, PhD
Research Sponsored by The Royal Ottawa Mental Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post treatment (~20 minutes)
Awards & highlights

Study Summary

Verbal episodic memory is an independent declarative memory system associated with language and is responsible for storage and conscious recall of previous personal experiences. Verbal episodic memory is impaired in schizophrenia and is related to patients' functional outcomes. Because no medication has shown clear positive effects on verbal memory impairment in schizophrenia, there is a great need to find effective cognitive remediation treatments (CRT) that could improve this domain in this psychiatric population. Although CRT programs have shown small to moderate positive effects on verbal memory in individuals with schizophrenia, traditional lab-based computerised cognitive interventions have notable attrition rates. In recent years, along with the advancement of technology, the development of Virtual Reality (VR) has allowed the possibility for new training techniques. Previous studies have established the initial feasibility and safety of using VR in schizophrenia population. However, no studies have examined the feasibility, safety and efficacy of combining VR technology with verbal memory training among individuals with schizophrenia. Thus, in this study, we will adapt an exercise from the Strategy for Semantic Association Memory (SESAME; (Guimond et al., 2018; Guimond & Lepage, 2016) training to a VR environment. We aim to determine the feasibility of using virtual reality in the context of a cognitive remediation intervention and to assess the initial efficacy of our verbal memory training on the use of semantic encoding strategies in people with schizophrenia. We also aim to assess participants' experience and tolerability of the VR training.

Eligible Conditions
  • Schizophrenia
  • Schizoaffective Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post treatment (~20 minutes)
This trial's timeline: 3 weeks for screening, Varies for treatment, and post treatment (~20 minutes) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in semantic encoding strategy use as measured by change in semantic clustering from baseline - the Hopkins Verbal Learning Test - Revisited (HVLT-R).
Feasibility of the intervention
Secondary outcome measures
Change in verbal memory performance from baseline
Participants' experience - Simulator sickness questionnaire (SSQ)
Participants' experience and tolerability - VR experience questionnaire

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Cognitive InterventionExperimental Treatment1 Intervention
Group II: Active Control InterventionActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Intervention
2016
N/A
~1120

Find a Location

Who is running the clinical trial?

The Royal Ottawa Mental Health CentreLead Sponsor
18 Previous Clinical Trials
2,060 Total Patients Enrolled
7 Trials studying Schizophrenia
356 Patients Enrolled for Schizophrenia
Synthia Guimond, PhDPrincipal InvestigatorRoyal Ottawa Mental Health Center
2 Previous Clinical Trials
142 Total Patients Enrolled
2 Trials studying Schizophrenia
142 Patients Enrolled for Schizophrenia

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby May 2025